FMT
GBT

First Mercantile Trust’s Global Blood Therapeutics, Inc. GBT Stock Holding History

First Mercantile Trust’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$93K Sell
3,651
-249
-6% -$7.32K 0.01% 677
2021
Q2 		$137K Sell
3,900
-216
-5% -$8.43K 0.02% 585
2021
Q1 		$168K Buy
+4,116
New +$189K 0.02% 507
2018
Q3 		– Sell
-1,423
Closed -$64K – 964
2018
Q2 		$64K Sell
1,423
-1,520
-52% -$69.2K 0.01% 791
2018
Q1 		$142K Buy
+2,943
New +$164K 0.03% 598

Other funds holding GBT

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

First Mercantile Trust's GBT Position: Q3 2021 in Review

First Mercantile Trust reduced its Global Blood Therapeutics, Inc. (GBT) stake by 6.4% in Q3 2021, selling an estimated $7.32K and leaving 3,651 shares worth $93K. The position accounts for 0.01% of the portfolio, ranked #677.

First Mercantile Trust first reported a position in GBT in Q1 2018 and has held it in 5 quarters since. The position peaked at $168K in Q1 2021. 187 funds tracked by Wall St. Rank hold GBT as of Q3 2021.

  • First Mercantile Trust held 3,651 shares of Global Blood Therapeutics, Inc. worth $93K as of Q3 2021.
  • First Mercantile Trust sold 249 Global Blood Therapeutics, Inc. shares in Q3 2021, an estimated $7.32K.
  • Global Blood Therapeutics, Inc. made up 0.01% of First Mercantile Trust's portfolio in Q3 2021, its #677 holding.
  • First Mercantile Trust first reported a position in Global Blood Therapeutics, Inc. in Q1 2018 and has held it in 5 quarters since.
  • First Mercantile Trust's Global Blood Therapeutics, Inc. position peaked at $168K in Q1 2021.
  • 187 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.